Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

NCT05404321 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT05404321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05404321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment
Lead sponsor
Centre Francois Baclesse
Phase
Observational
Overall status
Recruiting
Start date
January 9, 2023
Completion date
December 31, 2028
Enrollment
163 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

organoid, triple negative breast cancer